Figure 4 | Scientific Reports

Figure 4

From: ANXA2 is correlated with the molecular features and clinical prognosis of glioma, and acts as a potential marker of immunosuppression

Figure 4

Comparison of ANXA2 expression levels in different TCGA molecular subtypes. ANXA2 was significantly enriched in the mesenchymal subtype in TCGA (A) and CGGA (C) cohorts (P < 0.0001). ROC curve analysis showed the predictive value of ANXA2 for mesenchymal subtype in the TCGA and CGGA cohorts (B,D). *P < 0.05, **P < 0.01, ***P < 0.001, **** P < 0.0001.

Back to article page